litlas
Log inCreate account

Thomas R. E. Barnes

Active 1980–2025

101
Papers
20,371
Citations
80
h-index
98
i10-index

Citations

Citations per year for Thomas R. E. Barnes1983: 1 citations1984: 1 citations1985: 4 citations1986: 6 citations1987: 5 citations1988: 1 citations1989: 12 citations1990: 4 citations1991: 16 citations1992: 22 citations1993: 26 citations1994: 32 citations1995: 27 citations1996: 31 citations1997: 36 citations1998: 44 citations1999: 51 citations2000: 74 citations2001: 86 citations2002: 88 citations2003: 106 citations2004: 99 citations2005: 160 citations2006: 137 citations2007: 181 citations2008: 209 citations2009: 256 citations2010: 236 citations2011: 196 citations2012: 178 citations2013: 171 citations2014: 180 citations2015: 166 citations2016: 135 citations2017: 100 citations2018: 116 citations2019: 428 citations2020: 366 citations2021: 343 citations2022: 206 citations2023: 172 citations2024: 275 citations2025: 111 citations2026: 8 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,624 citing papers, 23.4% of this breakdownUnited Kingdom: 1,166 citing papers, 16.8% of this breakdownCanada: 438 citing papers, 6.3% of this breakdownGermany: 431 citing papers, 6.2% of this breakdownAustralia: 388 citing papers, 5.6% of this breakdownItaly: 257 citing papers, 3.7% of this breakdownSpain: 237 citing papers, 3.4% of this breakdownNetherlands: 229 citing papers, 3.3% of this breakdownChina: 168 citing papers, 2.5% of this breakdownSwitzerland: 145 citing papers, 2.1% of this breakdownDenmark: 133 citing papers, 1.9% of this breakdownFrance: 129 citing papers, 1.9% of this breakdown
0%23.4%Other 22.9%

Institutions

Fields

  • Medicine73.8%
  • Neuroscience12.2%
  • Psychology6.8%
  • Biochemistry, Genetics and Molecular Biology3.4%
  • Pharmacology, Toxicology and Pharmaceutics0.7%
  • Arts and Humanities0.6%
  • Other2.5%

Topics

  • Schizophrenia research and treatment20.2%
  • Bipolar Disorder and Treatment4.8%
  • Mental Health and Psychiatry4.5%
  • Cannabis and Cannabinoid Research4.3%
  • Tryptophan and brain disorders3.1%
  • Neurotransmitter Receptor Influence on Behavior2.9%
  • Other60.2%

Coauthors

All papers

Open in search
  1. The Maudsley Prescribing Guidelines in Psychiatry

    Authors: David Taylor, Thomas R. E. Barnes, Allan H. Young - 2021 cited by 981

  2. A Rating Scale for Drug-Induced Akathisia

    Authors: Thomas R. E. Barnes - The British Journal of Psychiatry 1989 cited by 2,175

  3. Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology

    Authors: Thomas R. E. Barnes, Richard Drake, Carol Paton, Stephen Cooper, J.F.W. Deakin, I. Nicol Ferrier, Catherine J. Gregory, Peter Haddad, Oliver Howes, Ian Jones, Eileen M. Joyce, Shôn Lewis, Anne Lingford‐Hughes, James H. MacCabe, David Owens, Maxine X. Patel, Julia Sinclair, James Stone, Peter S. Talbot, Rachel Upthegrove, Angelika Wieck, Alison R. Yung - Journal of Psychopharmacology 2019 cited by 596

  4. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review

    Authors: Theresa HM Moore, Stanley Zammit, Anne Lingford‐Hughes, Thomas R. E. Barnes, Peter B. Jones, Margaret Burke, Glyn Lewis - The Lancet 2007 cited by 2,223

  5. The relationship between negative symptoms and depression in schizophrenia: a systematic review

    Authors: Carl R. Krynicki, Rachel Upthegrove, J.F.W. Deakin, Thomas R. E. Barnes - Acta Psychiatrica Scandinavica 2018 cited by 225

  6. Antipsychotic dose reduction and discontinuation versus maintenance treatment in people with schizophrenia and other recurrent psychotic disorders in England (the RADAR trial): an open, parallel-group, randomised controlled trial

    Authors: Joanna Moncrieff, Nadia Crellin, Jacki Stansfeld, Ruth Cooper, Louise Marston, Nick Freemantle, Glyn Lewis, Rachael Hunter, Sonia Johnson, Thomas R. E. Barnes, Nicola Morant, Vanessa Pinfold, Ruth Smith, Lyn Kent, Katherine Darton, Maria Long, Mark Horowitz, Robert Horne, Victoria Vickerstaff, Mithilesh Jha, Stefan Priebe - The Lancet Psychiatry 2023 cited by 86

  7. The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial

    Authors: J.F.W. Deakin, John Suckling, Thomas R. E. Barnes, Kelly Byrne, Imran B. Chaudhry, Paola Dazzan, Richard Drake, Annalisa Giordano, Nusrat Husain, Peter B. Jones, Eileen M. Joyce, Emma Knox, Carl R. Krynicki, Stephen M. Lawrie, Shôn Lewis, Danuta M. Lisiecka-Ford, Naghmeh Nikkheslat, Carmine M. Pariante, Richard Smallman, Andrew Watson, Steven Williams, Rachel Upthegrove, Graham Dunn - The Lancet Psychiatry 2018 cited by 180

  8. Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group

    Authors: Elias Wagner, Dan Siskind, Peter Falkai, Oliver Howes, Christoph U. Correll, Jimmy Lee, William G. Honer, John M. Kane, Emilio Fernández-Egea, Thomas R. E. Barnes, Alkomiet Hasan, TRRIP Working Group, Ofer Agid, Celso Arango, Lone Baandrup, Thomas R. E. Barnes, Andrea de Bartolomeis, Nico J.M. van Beveren, Michael L. Birnbaum, István Bitter, Alain Breier, Robert W. Buchanan, William T. Carpenter, David Castle, Eric Chen, Leslie Citrome, David Cotter, Christoph U. Correll, Benedicto Crespo‐Facorro, Michael Davidson, Richard Drake, Sonia Dollfus, Serdar Dursun, Bjørn H. Ebdrup, Robin Emsley, Emilio Fernández-Egea, Hélio Elkis, Peter Falkai, Wolfgang Fleischhacker, Oliver Freudenreich, Ary Gadelha, Wolfgang Gäebel, Birte Glenthøj, Donald Goff, Ariel Graff‐Guerrero, Jorge Hallak, Alkomiet Hasan, William G. Honer, Philip Homan, Oliver Howes, René S. Kahn, Stefan Kaiser, John M. Kane, James L. Kennedy, Bruce J. Kinon, Euitae Kim, Stephen M. Lawrie, Jimmy Lee, Stefan Leucht, F. Markus Leweke, Jan Libiger, Antony Loebel, James H. MacCabe, Stephen R. Marder, Robert A. McCutcheon, Ingrid Melle, Herbert Y. Meltzer, Armida Mucci, Dieter Naber, Shinchiro Nakajima, Jimmi Nielsen, Oisín O’Brien, Akin Ojagbemi, Christos Pantelis, Joseph Peuskens, Steven G. Potkin, Tiago Reis Marques, Thomas J. Raedler, Gary Remington, Susan L. Rossell, Jose Rubio-Lorente, Gabriele Sachs, Dan Siskind, Cynthia Siu, Iris E. Sommer, Jun Soo Kwon, Takefumi Suzuki, Jaana Suvisaari, Hiroyoshi Takeuchi, Rajiv Tandon, David Taylor, Neil Thomas, Jari Tiihonen, Hiroyuki Uchida, Alp Üçok, Daniel Umbricht, Ganesan Venkatasubramanian, Elias Wagner, James Walters, Chuanyue Wang and 2 more - Schizophrenia Bulletin 2023 cited by 38

  9. Inflammatory subgroups of schizophrenia and their association with brain structure: A semi-supervised machine learning examination of heterogeneity

    Authors: Paris Alexandros Lalousis, Lianne Schmaal, Stephen J. Wood, Renate Reniers, Vanessa Cropley, Andrew Watson, Christos Pantelis, John Suckling, Nicholas M. Barnes, Carmine M. Pariante, Peter B. Jones, Eileen M. Joyce, Thomas R. E. Barnes, Stephen M. Lawrie, Nusrat Husain, Paola Dazzan, J.F.W. Deakin, Cynthia Shannon Weickert, Rachel Upthegrove - Brain Behavior and Immunity 2023 cited by 42

  10. Treatment Recommendations for Tardive Dyskinesia

    Authors: Lucia Ricciardi, Tamara Pringsheim, Thomas R. E. Barnes, Davide Martino, David M. Gardner, Gary Remington, Donald Addington, Francesca Morgante, Norman Poole, Alan Carson, Mark J. Edwards - The Canadian Journal of Psychiatry 2019 cited by 100

  11. Randomized Controlled Trial of Effect of Prescription of Clozapine Versus Other Second-Generation Antipsychotic Drugs in Resistant Schizophrenia

    Authors: Shôn Lewis, Thomas R. E. Barnes, Linda Davies, Robin Murray, G. Dunn, Karen P. Hayhurst, Alison Markwick, Helen Lloyd, Peter B. Jones - Schizophrenia Bulletin 2005 cited by 421

  12. The Assessment and Treatment of Antipsychotic-Induced Akathisia

    Authors: Tamara Pringsheim, David M. Gardner, Donald Addington, Davide Martino, Francesca Morgante, Lucia Ricciardi, Norman Poole, Gary Remington, Mark J. Edwards, Alan Carson, Thomas R. E. Barnes - The Canadian Journal of Psychiatry 2018 cited by 83

  13. Transcription and pathway analysis of the superior temporal cortex and anterior prefrontal cortex in schizophrenia

    Authors: Michael R. Barnes, Julie Huxley‐Jones, Peter R. Maycox, Mark Lennon, Amy Thornber, F. M. Kelly, Stewart Bates, Adam Taylor, Juliet Reid, Neil A. Jones, Jörn E. Schroeder, Carol A. Scorer, Ceri H. Davies, Jim J. Hagan, James N.C. Kew, Claire Angelinetta, Tariq Akbar, Steven R. Hirsch, Ann Mortimer, Thomas R. E. Barnes, Jackie de Belleroche - Journal of Neuroscience Research 2011 cited by 96

  14. Efficacy of oral versus long-acting antipsychotic treatment in patients with early-phase schizophrenia in Europe and Israel: a large-scale, open-label, randomised trial (EULAST)

    Authors: Inge Winter-van Rossum, Mark Weiser, Silvana Galderisi, Stefan Leucht, István Bitter, Birte Glenthøj, Alkomiet Hasan, Jurjen J. Luykx, Marina Kupchik, Georg Psota, Paola Rocca, Nikos Stefanis, Alexander Teitelbaum, Mor Bar Haim, Claudia Leucht, Georg Kemmler, Timo Schurr, René S. Kahn, Walter Wolfgang Fleischhacker, Michael Davidson, Inge Winter-van Rossum, Mark Weiser, Mark Weiser, Alkomiet Hasan, M.D. Mosescu, Silvana Galderisi, Marina Kupchik, Nikos Stefanis, Alexander Teitelbaum, Alexander Teitelbaum, Paola Rocca, George Umoh, George Umoh, Lucho G Hranov, Alex Hofer, Joachim Cordes, Ramin Nilforooshan, Julio Bobes, Solveig Klebo Reitan, Manuel Morrens, Aurel Nireştean, John Geddes, John Geddes, Marcin Olajossy, Alessandro Rossi, Erik Johnsen, Csekey László, Adela Magdalena Ciobanu, Peter Haddad, Igor Oife, Miquel Bernardo, Rodicutza Stan, Marek Jarema, Dan Rujescu, Libor Ustohal, Neil Mayfield, Paola Dazzan, Avi Valevski, Jan Libiger, Richard M. Köhler, Pavel Mohr, Sofia Pappa, Petros Drosos, Thomas R. E. Barnes, Esther DeClercq, Elias Wagner, Paola Bucci, Armida Mucci, Yaacov Rabinowitz, Adam Adamopoulous, Benjamin Draiman, Cristiana Montemagni, Manfred Greslechner, Hannah Herlihy, Csilla Bolyós, Christian Schmidt-Kraepelin, Jessica True, Leticia Alvarez Garcia, Berit Walla, Bernhard Sabbe, Lucaks Emese, Sarah Mather, Nikodem Skoczeń, Serena Parnanzone, Jill Bjarke, Krisztina Karácsonyi, Steve Lankshear, Marina Garriga, Adam Wichniak, Heidi Baumbach, Heidi Baumbach, Leonie Willebrands, Lyliana Nasib, Cynthia Okhuijsen‐Pfeifer, Elianne Huijsman, Michael Davidson, René S. Kahn, W.W. Fleischhacker, W.W. Fleischhacker, W.W. Fleischhacker - The Lancet Psychiatry 2023 cited by 48

  15. Clinical predictors of antipsychotic treatment resistance: Development and internal validation of a prognostic prediction model by the STRATA-G consortium

    Authors: Sophie E. Smart, Deborah Agbedjro, Antonio F. Pardiñas, Olesya Ajnakina, Luis Alameda, Ole A. Andreassen, Thomas R. E. Barnes, Domenico Berardi, Sara Camporesi, Martine Cleusix, Philippe Conus, Benedicto Crespo‐Facorro, Giuseppe D’Andrea, Arsime Demjaha, Marta Di Forti, Kim Q., Gillian A. Doody, Chin B. Eap, Aziz Ferchiou, Lorenzo Guidi, Lina Homman, Raoul Jenni, Eileen M. Joyce, Laura Kassoumeri, Ornella Lastrina, Ingrid Melle, Craig Morgan, F. Anthony O’Neill, Baptiste Pignon, Romeo Restellini, Jean‐Romain Richard, Carmen Simonsen, Filip Španiel, Andreı̈ Szöke, Ilaria Tarricone, Andrea Tortelli, Alp Üçok, Javier Vázquez-Bourgón, Robin Murray, James Walters, Daniel Ståhl, James H. MacCabe - Schizophrenia Research 2022 cited by 24

  16. Proceedings of the Seventh Workshop on Computational Linguistics and Clinical Psychology: Improving Access

    Authors: Glorianna Jagfeld, Fiona Lobban, Paul Rayson, Steven Jones, Guy M. Goodwin, Peter Haddad, I. Nicol Ferrier, Joseph Aronson, Thomas R. E. Barnes, Andrea Cipriani, David Coghill, Seena Fazel, John Geddes, Heinz Grunze, Emily A. Holmes, Oliver Howes, S. Hudson, N Hunt, Ian Jones, I. C. MacMillan, R. Hamish McAllister‐Williams, D Mik, Roger S. McIntyre, Sidney H. Kennedy, Joanna K. Soczynska, Ha H. Nguyen, Kathleen R. Merikangas, Robert Jin, Jianping He, Ronald C. Kessler, Sing Lee, Nancy Samp- Son, María Carmen Viana, Laura Helena Andrade, Chiyi Hu, Elie G. Karam, Maria Ladea, María Elena, Medina Mora, Mark Oakley, Keith Harrigian, Carlos Aguirre, Mark Dredze, Glen Coppersmith, Craig Harman, Kristy Hollingshead, Margaret Mitchell, Johannes C. Eichstaedt, Robert E. Smith, Raina Mer- Chant, Lyle Ungar, Hila Gonen, Yoav Goldberg, Yoav Goldberg, Adrian Benton, Glen Coppersmith, Mark Dredze, Liliana Dell, ' Osso, Barbara Carpita, Carlo Bertelloni, Elisa Diadema, Maria Filippo, Camilla Barberi, Claudia Gesi, Carmassi, Colin Depp, Dilip Jeste, Arianna Diflorio, Ian Jones, Gunther Eysenbach, James Till, J Alize, Emily Ferrari, Jon Stockings, Holly Khoo, Louisa Erskine, Theo Degenhardt, Harvey Vos, Whiteford, Robert Freedman, David Lewis, Robert Michels, Daniel Pine, Susan Schultz, Carol Tamminga, Glen Gabbard, Susan Shur-Fen, Daniel Gau, Maria Javitt, Patrick Oquendo, Eduard Shrout, Joel Vieta, Yager, Danielle Novick, Holly Swartz, Ellen Frank, O' Bridianne, Stephen Dea, Philip Wan and 2,489 more - 2021 cited by 21

  17. Randomized Controlled Trial of the Effect on Quality of Life of Second- vs First-Generation Antipsychotic Drugs in Schizophrenia

    Authors: Peter B. Jones, Thomas R. E. Barnes, Linda Davies, Graham Dunn, Helen Lloyd, Karen P. Hayhurst, Robin Murray, Alison Markwick, Shôn Lewis - Archives of General Psychiatry 2006 cited by 1,108

  18. Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology

    Authors: Thomas R. E. Barnes - Journal of Psychopharmacology 2011 cited by 353

  19. A window into the brain: An in vivo study of the retina in schizophrenia using optical coherence tomography

    Authors: Elvina Chu, Madhan Kolappan, Thomas R. E. Barnes, Eileen M. Joyce, María A. Ron - Psychiatry Research Neuroimaging 2012 cited by 134

  20. Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial

    Authors: Anthony P. Morrison, Melissa Pyle, Andrew Gumley, Matthias Schwannauer, Douglas Turkington, Graeme MacLennan, John Norrie, Jemma Hudson, Samantha Bowe, Paul French, Rory Byrne, Suzy Syrett, Robert Dudley, Hamish J. McLeod, Helen Griffiths, Thomas R. E. Barnes, Linda Davies, David Kingdon, Suzan Aydinlar, James Courtley, Maggie Douglas-Bailey, Elizabeth Graves, Natasha Holden, Jane L. Hutton, Paul Hutton, Susan Irving, Clare Jackson, Toyah Lebert, Helen Mander, Laura McCartney, Trevor Munro-Clark, Elizabeth Murphy, Mairi Spanswick, Ann Steele, Liesbeth Tip, Sarah Tully - The Lancet Psychiatry 2018 cited by 111

  21. A Randomized Controlled Trial of Cognitive-Behavioral Therapy for Persistent Symptoms in Schizophrenia Resistant to Medication

    Authors: Tom Sensky, Douglas Turkington, David Kingdon, Jan Scott, Jonathan W. Scott, Ronald Siddle, Madeline O'Carroll, Thomas R. E. Barnes - Archives of General Psychiatry 2000 cited by 697

  22. Movement Disorders Associated With Antipsychotic Medication in People With Schizophrenia: An Overview of Cochrane Reviews and Meta-Analysis

    Authors: Davide Martino, Vikram Karnik, Sydney Osland, Thomas R. E. Barnes, Tamara Pringsheim - The Canadian Journal of Psychiatry 2018 cited by 87

  23. Comorbid substance use and age at onset of schizophrenia

    Authors: Thomas R. E. Barnes, Stanley Mutsatsa, Sam Hutton, Hilary Watt, Eileen M. Joyce - The British Journal of Psychiatry 2006 cited by 272

  24. Do patients with schizophrenia exhibit aberrant salience?

    Authors: Jonathan P. Roiser, Klaas Ε. Stephan, Hanneke E.M. den Ouden, Thomas R. E. Barnes, Karl Friston, Eileen M. Joyce - Psychological Medicine 2008 cited by 265